I have to agree with you. When we came in years ago, the blue sky prognosis prevailed even when we didn't realised what hoops that were neeeded for MABR to jump through.
Since then, much has been accomplished. We have 200 plants in China, and it's spreading to Cambodia, Vietnam, Philippines, Ethiopia and
Ghana. Although pilot plants were ordered by
3 Gorges Group, we are also seeing bulk orders by
iTest and
Kaitian. That proves to me that momentum for MABR is growing. Going forward we will see more pilot plants ordered in the past will lead to bulk orders once the pilot plants have gathered enough data. It is not a concept anymore. The share price has taken out the hype and it has swung to the other extreme of despondency. However, not many have the liquidity to buy (ahem, me). But where we are in the share price, I think these levels have discounted Ivory Coast and CES. That be it as it may, the price now should be bought for MABR.
All the best.
.
